WIXLIB

SysmexSustainabilityReport2015Full Version

Contents123552Contents/Editorial PolicyCorporate PhilosophyMessage from the Chairman and CEOSysmex at a Glance7Highlight19Highlight2Involvement with Stakeholders53 Involvement with Customers54586263Ensuring Quality and SafetyAfter-Sales Support/Scientific ActivitiesStable SupplyEnhancing Customer Satisfactionand Third-Party Evaluations65 Contributing to Resolution ofHealthcare IssuesExpanding our Lineup of ImmunoassayAnalyzers and Reagents That Contributeto the Early Detection and Treatment ofInfectious Diseases, Cancer andOther Diseases67 Involvement with Shareholders69 Involvement with Business Partners73 Involvement with EmployeesOpening of i-Square, a Core InstrumentFactory Focused on DeliveringHigh-Quality Products in a Stable Manner74 Respecting Human Rights and Diversity77 Employee Evaluation, Treatment,and Human Resource Development83 Ensuring a Work-Life Balance87 Respecting Workers’ Rights88 Considering Safety and Health11Highlight313Employee Volunteers Conduct Fund-RaisingCampaign to Help Fight Cancer354250949810317 China18 Asia Pacific104CSR ManagementMid-Term CSR Plan113Results of Dialogue with Stakeholders117119122Summary of CSR DataExternal EvaluationCorporate GovernanceComplianceRisk Management12413613 7Policy on Corporate CitizenshipActivities and PhilanthropyActivities to Promote a Healthy SocietyContributing to Local CommunitiesPromoting Employees’ SocialContribution ActivitiesEnvironmental Conservation Activities105106111* Europe, the Middle East and AfricaSysmex’s CSR Activities2022242630Corporate Citizenship Activities93Global CSR Activity Highlights13 Japan15 Americas16 EMEA*1992Environmental PolicyEnvironmental ManagementEnvironmentally Conscious Productsand ServicesEnvironmental Consciousness atBusiness OfficesOther Environmental ConsiderationsGreen ProcurementEnvironmental DataGuideline Comparative TableIndependent OpinionCorporate InformationEditorial PolicyOrganizations coveredSysmex publishes the annual “Sysmex Sustainability Report”in the hopes of communicating its approaches and activitiesconcerning corporate social responsibility (CSR) to stakeholdersand facilitating dialog with them. This report is available as a fullversion and in digest form, as well as on the Company’s website.Sysmex Group (Sysmex Corporation and its subsidiaries both in Japan andabroad). In this report, “Sysmex” refers to the Sysmex Group as a whole.“Sysmex Corporation” refers to the Company on a stand-alone basis.Period coveredInformational content of each mediaconducted outside this period are also included. Comprehensive informationProvides exhaustive coverage of the Company’s CSR initiativesDate of publication August 2015 (Adding pages on December 2015 [P. 137-138])Excerpts of key information onlyContains excerpted content the Company wishes particularly tocommunicate to stakeholdersGuidelines referencedInquiries about this report The Global Reporting Initiative (GRI)'s Sustainability ReportingCSR Promotion Department, Sysmex Corporation The Japanese Ministry of the Environment's Environmental Reporting1

Corporate PhilosophyCore BehaviorsTo our CustomersWe deliver reassurance to our customers, through unmatched quality, advanced technologies, superior support,and actions that consistently reflect the viewpoint of our customers. We constantly look out for our customers’true needs, and seek to generate new solutions to satisfy those needs.To our EmployeesWe honor diversity, respect the individuality of each employee, and provide them with a workplace wherethey can realize their full potential. We value the spirit of independence and challenge, provide employeeswith opportunities for self-fulfillment and growth, and reward them for their accomplishments.To our Business PartnersWe deliver commitment to our client companies through broad-ranging partnerships. We strive to be a companythat can grow in step with our trade partners, through respect and mutual trust.To our ShareholdersOur shareholders can rest assured that we will continue to improve the soundness and transparency of ourmanagement policies, while promoting information disclosure and close communications. We commit ourselvesto a consistent yet innovative style of management, in order to achieve sustainable growth and increasedshareholder value.To SocietyWe carry out our business in strict compliance with laws and regulations, as well as in adherence to high ethicalstandards. As a responsible member of society, we play an active role in resolving environmental issues andother problems that impact our society today.2

Message from the Chairman and CEOWe address the shared desire of all people to remain healthyby providing products and services backed by leading-edgetechnologies and building trust and confidence.Contributing to the Advancement of Healthcarethrough Testingemerging markets, with these products we expect to provideadvanced testing in numerous regions and circumstances.In line with our mission of “shaping the advancement ofhealthcare,” which is defined in the “Sysmex Way,” thecorporate philosophy for the Sysmex Group, Sysmex worksto contribute to the development of healthcare and thehealthy lives of people. Since our founding in 1968, we havecreated a wide spectrum of products and services in thein-vitro diagnostics field based on advanced technologies,and the Group’s products are used in more than 190 countriesaround the world.In recent years, the environment surrounding thehealthcare business has changed dramatically. In advancedcountries, new needs are emerging as populations age andattention focuses on individually optimized healthcare(personalized medicine). Meanwhile, emerging markets—including China and countries in Southeast Asia and Centraland South America—are working to expand their healthcareinfrastructures and offer more sophisticated healthcare inline with their economic development.In this environment, testing is playing an increasinglyimportant role in illness prevention, early detection and thedetermination of treatment methods. We aim to swiftlyaddress these changes in the environment and respond topeople’s desire to remain healthy by meeting increasinglydiverse and advanced testing needs.In fiscal 2014, we launched the HISCL-800, a new productin the HISCL-Series of automated immunoassay analyzersthat aids in the diagnosis of infectious diseases, cancers, heartdiseases and autoimmune diseases and in monitoring theircourses of treatment. This product inherits such seriescharacteristics as minute samples, a high degree of sensitivityand fast measurement, and is compact, being approximately60% the width of existing models. We also introduced theXN-L-Series, a compact automated hematology analyzer.Aimed primarily to meet demand at small and medium-sizedfacilities in advanced markets and expected growth inBuilding Trust and Confidence amongStakeholdersIn keeping with its corporate philosophy, Sysmex prioritizesthe building of trust and confidence among its stakeholders.In fiscal 2014, we responded to growing global demandfor testing by reorganizing our instrument manufacturingstructure, creating a system to ensure the stable delivery ofproducts of even higher quality. We opened the doors ofi-Square, a new factory in the city of Kakogawa, HyogoPrefecture, and expanded the factories at two Groupcompanies in Japan. These moves will approximately tripleour future supply capacity at our four factories, includingKakogawa Factory. We also set up a logistics center withini-Square to directly link our manufacturing and distributionfunctions. At the same time, we revised our product packagingmaterials and promoted such reforms as increasing loadingratios. In addition to making logistics more efficient, thesemoves are helping to reduce our CO2 footprint. Overseas,we augmented production capacities at our reagentfactories in Singapore and Germany. As well as ensuringhigh levels of quality and production efficiency, we stroveto make these factories even more comfortable places foremployees to work.Besides its business-related initiatives, Sysmex alsoundertook a variety of social contribution activities. Forexample, because as a healthcare company we believe incontributing to a healthy society through sports, we havesupported the Kobe Marathon since its inception. We werea special sponsor of the fourth Kobe Marathon, which washeld in November 2014, and our volunteers supported eventoperations in such ways as providing water to runners.Overseas, we conduct a host of social contributionactivities tailored to the characteristics of individual regions.To help stamp out cancer, one of the world’s most deadly3

diseases, in fiscal 2014 we launched the Sysmex AgainstCancer campaign in the EMEA* region. Employee volunteersfrom different locations joined together in planning andconducting a variety of fund-raising events, with proceedsdonated to the World Cancer Research Fund.* Europe, the Middle East and AfricaAiming to Make Further Progress with a NewMid-Term Management PlanWe have recently formulated a new Group mid-termmanagement plan to guide Sysmex through fiscal 2017.In addition to developing high-value-added productsthat anticipate customers’ needs and rolling out a globalbusiness strategy, this plan calls for the Company toaugment management soundness and transparency byrevising its internal control system. These measures areintended to enhance our sustainable corporate value.We will also reinforce interactive communication withdiverse stakeholders.When formulating our mid-term management plan,we also revised our mid-term CSR plan. This plan is basedon the 10 principles of the United Nations Global Compact,which the Company joined in 2011, and ISO 26000. Theplan calls for further globalization of our businesses andre-establishes targets for future activities based on theincreasingly diverse and sophisticated demands andexpectations of our stakeholders.Sysmex aims to continue achieving sustainable growthgoing forward and strives to earn the trust of all ourstakeholders. As we undertake these endeavors, I ask for yourfurther understanding and support going forward.July 2015Hisashi IetsuguChairman and CEO4

Sysmex at a GlanceSupporting the Lives and Health of People Worldwide byProviding the Instruments, Reagents and Software used inIn-Vitro Diagnostics*Addressingthe ProblemsFaced byPatients andHealthcareProfessionalsReducing the Burden on PatientsHelping Physicians Diagnose SwiftlyReducing the Burden for LaboratoryTechnologists and Enhancing EfficiencySysmex productsare in usenear you.31132152